language_icon
EN
HI

JB Chemicals & Pharmaceuticals Share price

JBCHEPHARM

2005.4

35.20 (1.79%)
NSE
BSE
Last updated on 10 Apr, 2026 | 15:59 IST
Today's High

2009.00

Today's Low

1968.40

52 Week Low

1494.80

52 Week High

2195.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

JB Chemicals & Pharmaceuticals Chart

JB Chemicals & Pharmaceuticals Share Key Metrics

Volume
3.37 L
Market Cap
32198.44 CR
LTQ@LTP
1@2005.40
ATP
1986.4
Var Margin
13.49 %
Circuit Range
1576.2-2364.2
Delivery %
66.24 %
Value
66.91 CR
ASM/GSM
No
Market Lot
1

Summary

At 10 Apr, 2026 | 15:59, JB Chemicals & Pharmaceuticals share price stands at ₹2005.4, showing a 35.20% 1.79 for the day. The stock’s intraday movement has stayed between ₹1968.40 and ₹2009.00, while on a 52-week basis it has fluctuated from ₹1494.80 to ₹2195.00.
In terms of trading activity, JB Chemicals & Pharmaceuticals has recorded a volume of 336850 shares, with a market capitalisation of ₹160558706. The stock’s Average Traded Price (ATP) stands at ₹198640, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,200540. The stock operates within a circuit range of ₹1576.2-2364.2, with a Value of ₹66.91 CR. The Delivery Percentage for the day is 66.24%. Additionally, JB Chemicals & Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

JB Chemicals & Pharmaceuticals Fundamentals

View More
P/E Ratio

41.97

P/B Ratio

7.9

Div. Yield

0.79

Sector P/E

62.26

Sector P/B

3.36

Sec. Div. Yield

0.58

JB Chemicals & Pharmaceuticals Resistance and Support

Pivot 1965.6

Resistance

First Resistance

1987.7

Second Resistance

2005.2

Third Resistance

2027.3

Support

First Support

1948.1

Second Support

1926

Third Support

1908.5

JB Chemicals & Pharmaceuticals Futures & Options

Data Not Found

JB Chemicals & Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2019-20
Total Promoters
Segment
Percent

Total Promoters

53.66%

Mutual Fund

14.57%

Insurance

1.25%

Foreign Institutional Investors

14.65%

Domestic Institutional Investors

0.57%

Retail

15.29%

Others

0.01%

Total Promoters
MAR '24
53.78%
JUN '24
53.77%
SEP '24
53.74%
DEC '24
53.66%

JB Chemicals & Pharmaceuticals Corporate Actions

DateAgenda
2026-02-05Interim Dividend
2026-01-16Quarterly Results
2025-11-11Quarterly Results
2025-07-30Quarterly Results
2025-05-14Audited Results & Final Dividend
2025-02-04Quarterly Results & Interim Dividend

JB Chemicals & Pharmaceuticals News

JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Cessation

Mr. Nikhil Chopra has ceased to be the Chief Executive Officer and Key Managerial Personnel of JB Chemicals & Pharmaceuticals with effect from the closing of business hours of March 31, 2026. This resignation is due to personal reasons and to pursue other professional opportunities.
Apr 01 2026 13:04:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

J.B. Chemicals & Pharmaceuticals Limited announced that the National Company Law Tribunal (NCLT) has issued a Corrigendum Order related to its proposed amalgamation with Torrent Pharmaceuticals Limited. This update follows an earlier intimation regarding the scheme.
Mar 25 2026 19:03:00
Read More

About JB Chemicals & Pharmaceuticals

NSE : 1726  
BSE : 506943  
ISIN : INE572A01036  

The Company was incorporated in December 1976 in the nameof J.B. Mody Chemicals and Pharmaceuticals Ltd. Later thename was changed to J.B. Chemical and Pharmaceuticals Ltd.and a fresh Certificate of Incorporation upon change ofname was issued on 21/08/85 by the Registrar of CompaniesMaharashtra at Mumbai.J.B. Chemicals and Pharmaceuticals Ltd. is the flagship ofthe ''Unique'' group of companies. The Company was foundedby Mr. J.B. Mody along with his two brothers Mr. D.B.Mody and Mr. S.B. Mody. It is engaged in the business ofmanufacturing bulk drugs intermediates formulationsayurvedic and herbal preparations. The Company''smanufacturing facilities are situated at Thane BelapurAnkleshwar Panoli and Daman. The product rangemanufactured at each of the plants is given below:------------------------------------------------------------Plant Year in which Products manufacturedSite set up / acquired------------------------------------------------------------Thane 1985 formulationsBelapur 1985 bulk drugs and intermediates.Ankleshwar 1985 bulk drugs intermediates formulations based on metroni- dazole and diclofenac sodium.Panoli 1992 soft gelatine capsules. 1994 liquid formulations. 1995 bulk drug plant to manufacture diclofenac sodium and intermediates.Daman 1995 cardiovascular formulations mainly in the form of tables and capsules and ayurvedic preparations.------------------------------------------------------------JBCPLs multi-locational multi-products plants enable it tocater to a large portion of the market. Today the Companyhas 46 products catering to 11 therapeutic segments. It isranked 37th in terms of domestic retail sales amongst thepharmaceutical companies in India (Source : ORG).

Read More

JB Chemicals & Pharmaceuticals Management

NamePosition
Mr. Arun Duggal Chairman & Ind.Director
Mr. Nikhil Chopra WholeTime Director & CEO
View More

JB Chemicals & Pharmaceuticals FAQs

The Buying Price of JB Chemicals & Pharmaceuticals share is 2005.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy JB Chemicals & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for JB Chemicals & Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of JB Chemicals & Pharmaceuticals shares is 41.97. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio JB Chemicals & Pharmaceuticals shares is 7.9. Useful to assess the stock's value relative to its book value.

To assess JB Chemicals & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 62.26 & 3.36 with sector averages, along with growth rates and financial metrics.

The Market Cap of JB Chemicals & Pharmaceuticals is 32198.44 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of JB Chemicals & Pharmaceuticals share price is 2195.00 & 1494.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

JB Chemicals & Pharmaceuticals belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost